Updated COVID-19 Vaccines Providing Protection Against Omicron Variant Available at No Cost

Updated COVID-19 Vaccines Providing Protection Against Omicron Variant Available at No Cost

The Department of Health & Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has announced that people with Medicare, Medicaid, Children’s Health Insurance Program (CHIP) coverage, private insurance coverage, or no health coverage can get COVID-19 vaccines, including the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines, at no cost, for as long as the federal government continues purchasing and distributing these COVID-19 vaccines. Updated COVID-19 boosters add Omicron BA.4 and BA.5 spike protein components to the current vaccine composition, helping to restore protection that has diminished since previous vaccination by targeting variants that are more transmissible and immune-evading.

The boosters are authorized for use per the following:

  • Moderna COVID-19 Vaccine, Bivalent authorized for use in people ages 18 years and older.
  • Pfizer-BioNTech COVID-19 Vaccine, Bivalent authorized for use in people ages 12 years and older.

Authorized as single booster dose administered at least 2 months after either:

  • Completion of primary vaccination with any authorized or approved monovalent COVID-19 vaccine, or
  • Receipt of the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine.

Link to full News Alert: https://www.cms.gov/newsroom/news-alert/updated-covid-19-vaccines-providing-protection-against-omicron-variant-available-no-cost

In Case You Missed It: 

The CMS Office of Minority Health Director Dr. LaShawn McIver participated in a livestream forum with BlackDoctors.Org on October 4 to answer questions about vaccines including the newly updated COVID-19 vaccine. Click here to watch the session.

Helpful Resources

 

 

 

CMS Office of Minority Health  |  Working to Achieve Health Equity

Paid for by the US Department of Health and Human Services

Facebook
Twitter
Email